Skip to content

Nerve stimulation for treatment of pain in herpetic infection

Transcutaneous nerve stimulation with Stimpod(NMS460) as a part of multimodel approach for management of postherpetic neuralgia - A Randomized Double Blind Study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028456
Enrollment
50
Registered
2020-10-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: G548- Other nerve root and plexus disorders

Interventions

Intervention1: Stimpod (nms460): Study group will receive stimulation by Stimpod nms460 device. The stimulation will be given on the affected dermatomes at two points. First will be point of maximum p

Sponsors

Department of Anaesthesiology Critical Care JNMCH AMU Aligarh UP India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: age 18 years to 70 years Diagnosed case of post herpetic neuralgia Pain located at cervical, thoracic, lumbar or sacral region Patient willing to participate in the study

Exclusion criteria

Exclusion criteria: 1.Pregnant patient 2.Diabetic patients 3.Patient having in-dwelling electronic devices such as pacemaker, cochlear implants or other implants 4.Patients on anticoagulant therapy 5.Previous trauma in the dermatomal level affected with post herpetic neuralgia 6.Patients on treatment for vitamin B12 deficiency

Design outcomes

Primary

MeasureTime frame
To determine the degree and duration of pain relief in patients of post herpetic neuralgia using NRS(Numerical Rating Scale) Timepoint: 1st cycle Baseline, 4 hours 2nd cycle Preprocedure, 4hours 3rd cycle Preprocedure, 4hours 4th cycle Preprocedure, 4hours 5th cycle Preprocedure, 4hours 6th cycle Preprocedure, 4hours Follow up period 2nd,4th,6th week

Secondary

MeasureTime frame
To evaluate and compare the changes in quality of life (QoL) in the two groups of PHN To evaluate and access any complications arising due to the procedure Timepoint: 6th week of follow up

Countries

India

Contacts

Public ContactHammad Usmani

Department of Anaesthesiology & Critical Care, JNMCH, A.M.U, Aligarh, U.P, India,202002

hammadusmani2002@gmail.com9897114190

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026